Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Cavit Boz et al.|JAMA Neurology|2023Cited by 62
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Jan Hillert, Helmut Butzkueven et al.|Journal of Neurology|2024Cited by 12
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Alessio Signori, Suvitha Subramaniam et al.|Journal of Neurology Neurosurgery & Psychiatry|2024Cited by 4